While some studies suggest that daily supplementation may be more effective for neuropsychiatric symptoms such as anxiety and depression, bolus administration has been linked to greater reductions in inflammatory markers, particularly IL-6 [59,60]. This evidence concerns the gene IL6 and depressive disorder.